Financhill
Buy
72

SWI Quote, Financials, Valuation and Earnings

Last price:
$18.41
Seasonality move :
0.35%
Day range:
$18.32 - $18.37
52-week range:
$10.14 - $18.55
Dividend yield:
0%
P/E ratio:
29.08x
P/S ratio:
4.00x
P/B ratio:
2.24x
Volume:
1.2M
Avg. volume:
1.7M
1-year change:
47.86%
Market cap:
$3.1B
Revenue:
$796.9M
EPS (TTM):
$0.63

SWI Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for SolarWinds shares anticipate an average target of $17.14, ranging from a low estimate of $14.00 to a high estimate of $18.50. This average target implies a growth of -6.43% compared to the current stock price of $18.32.

Consensus Price Target

$17.14

Highest Price Target

$18.50

Lowest Price Target

$14.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 0

Hold 6 7 7

Sell 0 0 0
Consensus Hold Hold Hold

SWI Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock